Arbutus Biopharma Corp - FORM 10-K - EX-32.1 - EXHIBIT 32.1 - March 13, 2015

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Arbutus Biopharma Corpexh_322.htm
EX-23.1 - EXHIBIT 23.1 - Arbutus Biopharma Corpexh_231.htm
EX-21.1 - EXHIBIT 21.1 - Arbutus Biopharma Corpexh_211.htm
EX-31.2 - EXHIBIT 31.2 - Arbutus Biopharma Corpexh_312.htm
EX-10.51 - EXHIBIT 10.51 - Arbutus Biopharma Corpexh_1051.htm
EX-10.50 - EXHIBIT 10.50 - Arbutus Biopharma Corpexh_1050.htm
EX-10.53 - EXHIBIT 10.53 - Arbutus Biopharma Corpexh_1053.htm
EX-10.54 - EXHIBIT 10.54 - Arbutus Biopharma Corpexh_1054.htm
EX-10.59 - EXHIBIT 10.59 - Arbutus Biopharma Corpexh_1059.htm
EX-10.44 - EXHIBIT 10.44 - Arbutus Biopharma Corpexh_1044.htm
EX-10.64 - EXHIBIT 10.64 - Arbutus Biopharma Corpexh_1064.htm
EX-10.73 - EXHIBIT 10.73 - Arbutus Biopharma Corpexh_1073.htm
EX-10.66 - EXHIBIT 10.66 - Arbutus Biopharma Corpexh_1066.htm
EX-10.65 - EXHIBIT 10.65 - Arbutus Biopharma Corpexh_1065.htm
EX-10.41 - EXHIBIT 10.41 - Arbutus Biopharma Corpexh_1041.htm
EX-10.70 - EXHIBIT 10.70 - Arbutus Biopharma Corpexh_1070.htm
EX-10.69 - EXHIBIT 10.69 - Arbutus Biopharma Corpexh_1069.htm
EX-10.47 - EXHIBIT 10.47 - Arbutus Biopharma Corpexh_1047.htm
EX-10.75 - EXHIBIT 10.75 - Arbutus Biopharma Corpexh_1075.htm
EX-10.40 - EXHIBIT 10.40 - Arbutus Biopharma Corpexh_1040.htm
EX-10.49 - EXHIBIT 10.49 - Arbutus Biopharma Corpexh_1049.htm
EX-10.71 - EXHIBIT 10.71 - Arbutus Biopharma Corpexh_1071.htm
EX-10.56 - EXHIBIT 10.56 - Arbutus Biopharma Corpexh_1056.htm
EX-10.76 - EXHIBIT 10.76 - Arbutus Biopharma Corpexh_1076.htm
EX-10.67 - EXHIBIT 10.67 - Arbutus Biopharma Corpexh_1067.htm
EX-10.52 - EXHIBIT 10.52 - Arbutus Biopharma Corpexh_1052.htm
EX-10.58 - EXHIBIT 10.58 - Arbutus Biopharma Corpexh_1058.htm
EX-10.62 - EXHIBIT 10.62 - Arbutus Biopharma Corpexh_1062.htm
EX-10.61 - EXHIBIT 10.61 - Arbutus Biopharma Corpexh_1061.htm
EX-10.63 - EXHIBIT 10.63 - Arbutus Biopharma Corpexh_1063.htm
EX-10.74 - EXHIBIT 10.74 - Arbutus Biopharma Corpexh_1074.htm
EX-10.77 - EXHIBIT 10.77 - Arbutus Biopharma Corpexh_1077.htm
EX-10.60 - EXHIBIT 10.60 - Arbutus Biopharma Corpexh_1060.htm
EX-10.45 - EXHIBIT 10.45 - Arbutus Biopharma Corpexh_1045.htm
EX-10.72 - EXHIBIT 10.72 - Arbutus Biopharma Corpexh_1072.htm
EX-10.55 - EXHIBIT 10.55 - Arbutus Biopharma Corpexh_1055.htm
EX-10.43 - EXHIBIT 10.43 - Arbutus Biopharma Corpexh_1043.htm
EX-10.39 - EXHIBIT 10.39 - Arbutus Biopharma Corpexh_1039.htm
EX-10.42 - EXHIBIT 10.42 - Arbutus Biopharma Corpexh_1042.htm
EX-10.46 - EXHIBIT 10.46 - Arbutus Biopharma Corpexh_1046.htm
EX-10.48 - EXHIBIT 10.48 - Arbutus Biopharma Corpexh_1048.htm
EX-10.57 - EXHIBIT 10.57 - Arbutus Biopharma Corpexh_1057.htm
EXCEL - IDEA: XBRL DOCUMENT - Arbutus Biopharma CorpFinancial_Report.xls
10-K - FORM 10-K - Arbutus Biopharma Corpf10k_031215.htm
EX-31.1 - EXHIBIT 31.1 - Arbutus Biopharma Corpexh_311.htm
EX-10.68 - EXHIBIT 10.68 - Arbutus Biopharma Corpexh_1068.htm
Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Tekmira Pharmaceuticals Corporation (the “Company”) on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Mark J. Murray, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 

 
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2.
The information contained in the Report fairly represents, in all material respects, the financial condition and results of the operations of the Company.
 
Date: March 13, 2015
       
 
/s/ Mark J. Murray
 
Name:
  
Mark J. Murray
 
Title:
  
President and Chief Executive Officer

Stock widget

Investing forum

Arbutus Biopharma Corp Reports